Latest Asx Listings News

Delta Lithium has announced a substantial 46% increase in the gold resource at its Mt Ida Project, now exceeding 1.1 million ounces, alongside plans to spin off its gold assets into a new ASX-listed entity, Ballard Mining.

H&G High Conviction Limited has completed a major asset divestment, distributing over 63 million Hancock & Gore shares to its shareholders and signaling potential delisting and strategic shifts ahead.

Vital Metals is nearing completion of a pivotal Scoping Study for its Tardiff deposit in Canada, while spearheading a new Canadian rare earths consortium and securing fresh funding to support its development ambitions.

Boss Energy Limited reported a solid first quarter for 2025, posting positive net cash from operating activities and maintaining robust cash reserves despite ongoing investing outflows.

Wingara Limited has entered an exclusive agreement with Terra Firma Limited to explore and acquire meat industry businesses, securing $750,000 in initial funding. Trading on the ASX is suspended pending re-compliance and relisting.

Tempest Minerals has raised $400,000 through a placement and plans a $1.47 million entitlement issue to advance its gold exploration and Remorse Iron development in Western Australia.

Minerals 260 Limited has launched a $200-$220 million public offer to fund the acquisition of the Bullabulling Gold Project in Western Australia, featuring a 2.3 million ounce JORC-compliant resource. The company seeks ASX re-admission following a significant change in scale of activities.

Corporate Travel Management Limited has announced an unfranked dividend of AUD 0.10 per share for the six months ending December 31, 2024, payable on April 4, 2025.

AUCyber Limited has announced a significant reshuffle of its leadership team, appointing Chris Wright as CEO and welcoming three new non-executive directors, signaling a strategic pivot for the cyber security firm.

Bendigo and Adelaide Bank clarifies a modest 5.8% variance in half-year cash earnings against market forecasts, confirming no material surprise and compliance with ASX disclosure rules.

Nyrada Inc. posted a significant $2.46 million loss for H1 FY25, driven by increased R&D spend, while advancing its lead drug NYR-BI03 into first-in-human trials following regulatory approval.

Mt Malcolm Mines NL has reached a significant production milestone within 3.5 years of its ASX listing, generating initial revenue from gold sales while expanding its exploration footprint across multiple prospects in Western Australia's Leonora region.